B-Cell Prolymphocytic Leukemia: Clinical Trials

6 trials for B-Cell Prolymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 1 active not recruiting. 6 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Unknown 3, Completed 2, Active not recruiting 1
Phase 24Unknown 3, Completed 1

Follow B-Cell Prolymphocytic Leukemia: new trials by email Literature Review of B-Cell Prolymphocytic Leukemia trials Research Report on B-Cell Prolymphocytic Leukemia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma
Ibrutinib, Laboratory Biomarker Analysis, Pevonedistat - B-Cell Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia
Phase 1CompletedCity of Hope Medical Center182018-04-272026-11-10
Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
Entospletinib, Laboratory Biomarker Analysis, Obinutuzumab - Anemia, B-Cell Prolymphocytic Leukemia
Phase 1 / Phase 2CompletedAlexey Danilov, MD242017-07-172023-08-08
CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
PCAR-019 (anti-CD19 CAR-T cells) - Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia
Phase 1 / Phase 2UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102016-10-012016-10-25
PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and Lymphoma
anti-CD19 CAR-NK cells - Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia
Phase 1 / Phase 2UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102016-09-012016-12-06
Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
PCAR-019 (anti-CD19 CAR-T cells) - Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia
Phase 1 / Phase 2UnknownPersonGen BioTherapeutics (Suzhou) Co., Ltd.102016-07-012016-08-01
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes, Bendamustine Hydrochloride, Cyclophosphamide - B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia
Phase 1Active not recruitingCity of Hope Medical Center372014-10-142026-10-26

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (6)  ·  Leukemia, Prolymphocytic, B-Cell (6)  ·  Lymphoma, Follicular (6)  ·  Lymphoma, Mantle-Cell (6)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Leukemia, Hairy Cell (2)  ·  Anemia (1)  ·  Burkitt Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)

Broader conditions

Chronic Disease (6)  ·  Disease Attributes (6)  ·  Hematologic Diseases (6)  ·  Hemic and Lymphatic Diseases (6)  ·  Immune System Diseases (6)  ·  Immunoproliferative Disorders (6)  ·  Leukemia (6)  ·  Leukemia, B-Cell (6)  ·  Leukemia, Lymphoid (6)  ·  Leukemia, Prolymphocytic (6)  ·  Lymphatic Diseases (6)  ·  Lymphoma (6)  ·  Lymphoproliferative Disorders (6)  ·  Neoplasms (6)  ·  Neoplasms by Histologic Type (6)

Interventions

Antigens, CD19 (3)  ·  Sensitivity and Specificity (3)  ·  Immunotherapy, Adoptive (2)  ·  6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine (1)  ·  Bendamustine Hydrochloride (1)  ·  Cyclophosphamide (1)  ·  Etoposide (1)  ·  Pharmacogenomic Variants (1)  ·  fludarabine phosphate (1)  ·  ibrutinib (1)  ·  obinutuzumab (1)  ·  pevonedistat (1)

Sponsors

PersonGen BioTherapeutics (Suzhou) Co., Ltd. (3)  ·  City of Hope Medical Center (2)  ·  Alexey Danilov, MD (1)

Countries

China (3)  ·  United States (3)

Top investigators

Alexey Danilov (1)  ·  Craig Okada, M.D. (1)  ·  Lin Yang, Ph.D. (1)  ·  Tanya Siddiqi (1)  ·  Xin Liu, Ph.D. (1)  ·  Xingbing Wang, Ph.D. (1)

Results publications

PMID 28054442, PMID 34196037, PMID 34492703, PMID 34515338, PMID 36631449

NIH funding

P30CA033572 (1), P30CA069533 (1)